News
SINGAPORE: Singapore-headquartered biotech firm Hummingbird Bioscience, known for developing antibodies for cancer, is ...
FibroSIGHT™ Plus marks another advancement in HistoIndex’s efforts to integrate its digital pathology solutions into routine ...
HistoIndex, a pioneering leader in digital pathology solutions for chronic liver disease, has announced the launch of ...
Early combination therapy could translate into fewer downstream hospitalizations and lower costs associated with dialysis and cardiovascular complications.
6h
Stockhead on MSNClock ticking as Argenica nears phase II stroke trial readoutThe countdown is on with Argenica’s phase II trial results of lead drug ARG-007 in acute ischaemic stroke patients forecast .
Studying dogs and cancer is a way to learn about cancer in people. It’s not that dogs and owners share exposures to ...
A professor has said how he is 'impressed' with tests carried out on lab mice that could prove groundbreaking in the race for a cure.
In a major advance for patients with Crohn’s disease, a new study led by researchers at Mount Sinai Health System found that ...
Discover the latest breakthroughs in oncology, including FDA approvals and innovative therapies reshaping cancer treatment ...
The uncertainty surrounds who will be able to get updated vaccines in coming months – shots created to protect against more ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results